Literature DB >> 7539448

Obstructive azoospermia with agenesis of vas deferens or with bronchiectasia (Young's syndrome): a genetic approach.

D Le Lannou1, P Jezequel, M Blayau, I Dorval, P Lemoine, A Dabadie, M Roussey, B Le Marec, J Y Legall.   

Abstract

Two groups of infertile men with obstructive azoospermia were screened for cystic fibrosis (CF) gene mutations (delta F508, exons 3, 4, 7, 10, 11, 14a, 17b, 19, 20, 21). The first group was composed of 26 patients with congenital agenesis of vas deferens (CAVD). The second group was composed of 12 patients with obstructive azoospermia associated with chronic suppurating respiratory disease (Young's syndrome). Of the group with CAVD, 77% of patients showed at least one mutation in the CF transmembrane conductance regulator (CFTR) gene. The delta F508 mutation occurred most frequently (54%), and the second most frequent mutation to occur was R117H (27%). Six patients were double heterozygotes. In Young's syndrome, no CF mutations were detected. CAVD can be considered as an incomplete clinical form of CF. However, the differences observed in CF mutations between CF and CAVD suggest that they are different disorders resulting from mutations in the same gene. Young's syndrome is a very different clinical entity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539448     DOI: 10.1093/oxfordjournals.humrep.a135939

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  4 in total

1.  Identification of a novel mutation in CFTR gene exon 8 (L375F) in a CUAVD phenotype.

Authors:  P Jézéquel; B Chauvel; A Le Treut; J Y Le Gall; V David; D Le Lannou; M Blayau
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

Review 2.  Mendelian genetics of male infertility.

Authors:  Kathleen Hwang; Alexander N Yatsenko; Carolina J Jorgez; Sarmistha Mukherjee; Roopa Lata Nalam; Martin M Matzuk; Dolores J Lamb
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

3.  Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels.

Authors:  J E Mickle; M I Milewski; M Macek; G R Cutting
Journal:  Am J Hum Genet       Date:  2000-04-04       Impact factor: 11.025

4.  Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.

Authors:  Kristina V Krasnov; Maria Tzetis; Jie Cheng; William B Guggino; Garry R Cutting
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.